Efficacy of recombinant human parathyroid hormone 1-34(rhPTH1-34) in post-menopausal osteoporosis
ZHU Xian-jun,ZHANG Xue-jun,LI Peng-qiu
DOI: https://doi.org/10.3969/j.issn.1004-0501.2011.07.016
2011-01-01
Abstract:Objective To investigate the effect of rhPTH1-34 in treating post-menopausal osteoporosis.Methods 50 patients with post-menopausal osteoporosis were invided into 2 groups randomly and an open,controlled trial was conducted.The treating group included 37 patients,they received rhPTH 1-34 20μg/d,IH;The controlled group included 13 patients,they received Calcitonin 20U/w,IM,all of them received Caltrate With VitaminD600 Tablets 0.6g/d,orally.This two groups were treated for 6 months.Results At base line,this two groups showed no significant difference in ages,BMD of L1-4,average BMD of lumbar,and trochanter of femur,but they showed significant difference in BMD of femoral neck and Ward's area.This two groups droped one patient respectively;By the end of the trial,BMD of L2 of the treating group increased more significantly than that of the controlled group(P<0.05),BMD of femoral neck increased less than that of the controlled group(P<0.05),BMD of Ward's area decreased,also less than that of the controlled group(P<0.05),BMD of other sites showed no significant differences(P>0.05);As for the treating group itself,BMD of L1、L2、L3、L4 and average BMD of lumbar increased significantly(P<0.05),BMD of femoral neck and trochanter of femur increased,but not significantly(P>0.05),BMD of Ward's area decreased,but also not significantly(P>0.05);As for the controlled group,BMD of L3 and average BMD of lumbar increased significantly(P<0.05),BMD of L1、L2、L4、femoral neck and Ward's area increased,but not significantly(P>0.05),BMDof trochanter of femur decreased,but also not significantly(P>0.05);2 new fractures occurred in the treating group,one was fracture of the right humerus,the other was compressed fracture of lumbar;1 new fracture of right fibula occurred in the controlled group;The insidence of side effects were similar in this two groups.Conclusion Efficacy of rhPTH1-34 was similar to that of Calcitonin in treating post-menopausal osteoporosis,and it's safe,with light side effects.